Paul Matteis Stifel Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
62.1%
Neutral
37.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Maintained
| $77 |
3%
downside
| 2 | – |
–
| 26 Feb ‘26 6 days ago |
|
|
|
Hold
Maintained
| $24 |
3%
upside
| 2 | – |
–
| 26 Feb ‘26 6 days ago |
|
|
|
Hold
Maintained
| $466 |
2%
downside
| 3 | – |
–
| 13 Feb ‘26 19 days ago |
|
|
|
Buy
Maintained
| $40 |
342%
upside
| 2 | -3.8% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $188 |
41%
upside
| 3 | -0.3% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $35 |
43%
upside
| 2 | +28% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $39 |
156%
upside
| 2 | +38% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $508 |
55%
upside
| 3 | +13% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Initiated
| $28 |
55%
upside
| 1 | +36% |
0
%
| 21 Nov ‘25 3 months ago |
|
|
|
Hold
Maintained
| $3 |
2%
downside
| 2 | – |
–
| 17 Nov ‘25 3 months ago |
|
|
|
Hold
Downgraded
| $61 |
1%
upside
| 2 | +0.25% |
0
%
| 6 Nov ‘25 3 months ago |
|
|
|
Buy
Upgraded
| $202 |
6%
upside
| 1 | +24% |
0
%
| 6 Nov ‘25 3 months ago |
|
|
|
Buy
Maintained
| $12 |
78%
upside
| 1 | +154% |
0
%
| 25 Sep ‘25 5 months ago |
|
|
|
Buy
Maintained
| $94 |
3%
upside
| 2 | +32% |
0
%
| 29 May ‘25 9 months ago |
|
|
|
Hold
Downgraded
| $8 |
1%
downside
| 1 | – |
–
| 28 May ‘25 9 months ago |
|